BlackRock’s Denali Therapeutics DNLI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $178M | Buy |
|
|||||
|
2025
Q2 | $169M | Sell |
|
|||||
|
2025
Q1 | $188M | Sell |
|
|||||
|
2024
Q4 | $284M | Buy |
|
|||||
|
2024
Q3 | $402M | Buy |
|
|||||
|
2024
Q2 | $306M | Buy |
|
|||||
|
2024
Q1 | $250M | Buy |
|
|||||
|
2023
Q4 | $248M | Buy |
|
|||||
|
2023
Q3 | $225M | Buy |
|
|||||
|
2023
Q2 | $298M | Buy |
|
|||||
|
2023
Q1 | $218M | Buy |
|
|||||
|
2022
Q4 | $259M | Buy |
|
|||||
|
2022
Q3 | $264M | Sell |
|
|||||
|
2022
Q2 | $259M | Buy |
|
|||||
|
2022
Q1 | $263M | Buy |
|
|||||
|
2021
Q4 | $362M | Buy |
|
|||||
|
2021
Q3 | $381M | Buy |
|
|||||
|
2021
Q2 | $552M | Buy |
|
|||||
|
2021
Q1 | $375M | Buy |
|
|||||
|
2020
Q4 | $534M | Buy |
|
|||||
|
2020
Q3 | $218M | Sell |
|
|||||
|
2020
Q2 | $151M | Buy |
|
|||||
|
2020
Q1 | $92.2M | Buy |
|
|||||
|
2019
Q4 | $91.4M | Buy |
|
|||||
|
2019
Q3 | $80.4M | Buy |
|
|||||
|
2019
Q2 | $107M | Buy |
|
|||||
|
2019
Q1 | $106M | Sell |
|
|||||
|
2018
Q4 | $94.5M | Buy |
|
|||||
|
2018
Q3 | $71.9M | Buy |
|
|||||
|
2018
Q2 | $17.1M | Buy |
|
|||||
|
2018
Q1 | $20.8M | Buy |
|